SEC Form D · filed December 4, 2023
Graviton BioScience Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
David D. Macmillan · Princeton, NJDirectorSamuel D. Waksal · New York, NYExec · DirectorRan D. Nussbaum · Herzliya, L3DirectorJeremy D. Levin · New York, NYDirectorBihua D. Chen · Boston, MADirectorStelios D. Papadopoulos · New York, NYDirectorJames D. Boylan · New York, NYDirectorSamuel D. Waksal · New York, NYExec · DirectorDavid D. Macmillan · Princeton, NJDirectorStelios D. Papadopoulos · New York, NYDirectorRan D. Nussbaum · Herzliya, L3DirectorJames D. Boylan · New York, NYDirectorJeremy D. Levin · New York, NYDirectorBihua D. Chen · Boston, MADirectorJoel Barthelemy · Phoenix, AZDirectorMaxim Capital Partners, LLC · New York, NYDirectorMaxim Capital Group, LLC · New York, NYExec · DirectorDamian Vila · Manati, Puerto RicoDirectorNolen S. Taylor · Denver, CODirectorCooper Jordan · ATLANTIC CITY, NJDirectorCharles Clinton · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗